Search Results - "Balicer, RD"

Refine Results
  1. 1
  2. 2
  3. 3

    Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease by Israeli, E, Grotto, I, Gilburd, B, Balicer, R D, Goldin, E, Wiik, A, Shoenfeld, Y

    Published in Gut (01-09-2005)
    “…Background and aims: Several antibodies have been reported in the sera of patients with Crohn’s disease (CD) and ulcerative colitis (UC). The most commonly…”
    Get full text
    Journal Article
  4. 4

    Primary Prevention of Hyperlipidemia: Treatment and Compliance in Real World Practice by Avgil Tsadok, M, Feldman, B, Bachrach, A, Balicer, RD

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: Hyperlipidemia is a major cause of disease burden globally due to its role in cardiovascular disease (CVD). Primary prevention and treatment of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    IDENTIFICATION OF PATIENTS AT-RISK FOR 30-DAY READMISSION WHO SHOULD BE INCLUDED IN PREVENTION INTERVENTIONS: ASSESSMENT OF HOSPITAL AND COMMUNITY HEALTHCARE PROVIDERS by Flaks-Manov, N, Srulovici, E, Yahalom, R, Peri-Mazra, H, Reem, L, Key, C, Hoshen, M, Balicer, RD, Shadmi, E

    Published in Value in health (01-05-2017)
    “…OBJECTIVES: Increasingly, big-data electronic health record warehouses are used for developing and implementing high-risk identification algorithms for…”
    Get full text
    Journal Article
  14. 14

    Local public health workers' perceptions toward responding to an influenza pandemic by Balicer, Ran D, Omer, Saad B, Barnett, Daniel J, Everly, Jr, George S

    Published in BMC public health (18-04-2006)
    “…Current national preparedness plans require local health departments to play an integral role in responding to an influenza pandemic, a major public health…”
    Get full text
    Journal Article
  15. 15

    Creating Individualized HBA1C Targets Using Predictive Modeling by Karpati, T, Curtis, BH, Feldman, B, Strizek, AA, Leventer-Roberts, M, He, X, Raz, I, Levin Iaina, N, Rubin, G, Balicer, RD

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: Glycemic targets (HbAlc) have been recommended to guide therapeutic treatment for patients with type 2 diabetes mellitus (T2DM) and reduce the risk…”
    Get full text
    Journal Article
  16. 16

    CHOICE OF INJECTABLE THERAPY IN THE TYPE 2 DIABETES TRAJECTORY: SOCIO-DEMOGRAPHIC AND CLINICAL CHARACTERISTICS by Reges, O, Feldman, B, Gofer, I, Karpati, T, Leibowitz, M, Balicer, RD, Curtis, BH, He, X, Rubin, G, Strizek, AA, Leventer-Roberts, M

    Published in Value in health (01-05-2017)
    “…OBJECTIVES: Injectable therapy is required when patients with Type 2 Diabetes do not achieve glycemic control despite previous dietary and lifestyle…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Cost-benefit of stockpiling drugs for influenza pandemic by Balicer, Ran D, Huerta, Michael, Davidovitch, Nadav, Grotto, Itamar

    Published in Emerging infectious diseases (01-08-2005)
    “…We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current…”
    Get full text
    Journal Article
  20. 20